Literature DB >> 33301173

Characterizing clinics with differential changes in the screening rate in the Colorectal Cancer Control Program of the Centers for Disease Control and Prevention.

Krishna P Sharma1, Steven Leadbetter1, Amy DeGroff1.   

Abstract

BACKGROUND: The Centers for Disease Control and Prevention (CDC) funds the Colorectal Cancer Control Program (CRCCP) to increase colorectal cancer (CRC) screening rates in primary care clinics by implementing evidence-based interventions (EBIs). This study examined differences in clinic characteristics and implementation efforts among clinics with differential changes in screening rates over time.
METHODS: CRCCP clinic data collected by the CDC were used. The outcome was the clinic status (highest quartile [Q4] vs lowest quartile [Q1]), which was based on the absolute screening rate change between the first and second program years. Five clinic characteristic variables and 12 clinic-level CRCCP variables (eg, EBIs) were assessed in bivariable analyses, and logistic regression was used to determine significant predictors of the outcome.
RESULTS: Each group included 78 clinics (N = 156). Clinics with a Q4 status saw a 14.9 percentage point increase in the screening rate, whereas clinics with a Q1 status experienced a 9.1 percentage point decline. Q4s were more likely than Q1s to have a CRC champion, implement 4 EBIs versus fewer EBIs, implement at least 1 new EBI, and increase the number of implemented EBIs. The adjusted odds of Q4 status were 5.3 times greater (95% confidence interval [CI], 1.9-14.9) if a clinic implemented an additional EBI. The adjusted odds of Q4 status increased to 7.1 (95% CI, 2.2-23.1) if a clinic implemented 2 to 4 additional EBIs.
CONCLUSIONS: Implementing new EBIs or enhancing existing ones improves CRC screening rates. Additionally, clinics with lower screening rates had greater rate increases and may have benefited more from the CRCCP.
© 2020 American Cancer Society.

Entities:  

Keywords:  US Centers for Disease Control and Prevention; colorectal cancer screening; colorectal neoplasms; early detection of cancer; evidence-based medicine; primary health care

Mesh:

Year:  2020        PMID: 33301173      PMCID: PMC9242539          DOI: 10.1002/cncr.33325

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.921


  7 in total

Review 1.  Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation.

Authors:  Joseph A Durlak; Emily P DuPre
Journal:  Am J Community Psychol       Date:  2008-06

2.  Outreach and Inreach Strategies for Colorectal Cancer Screening Among Latinos at a Federally Qualified Health Center: A Randomized Controlled Trial, 2015-2018.

Authors:  Sheila F Castañeda; Balambal Bharti; Marielena Rojas; Silvia Mercado; Adriana M Bearse; Jasmine Camacho; Manuel Song Lopez; Fatima Muñoz; Shawne O'Connell; Lin Liu; Gregory A Talavera; Samir Gupta
Journal:  Am J Public Health       Date:  2020-02-20       Impact factor: 9.308

3.  Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Kirsten Bibbins-Domingo; David C Grossman; Susan J Curry; Karina W Davidson; John W Epling; Francisco A R García; Matthew W Gillman; Diane M Harper; Alex R Kemper; Alex H Krist; Ann E Kurth; C Seth Landefeld; Carol M Mangione; Douglas K Owens; William R Phillips; Maureen G Phipps; Michael P Pignone; Albert L Siu
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

4.  Annual report to the nation on the status of cancer, part I: National cancer statistics.

Authors:  S Jane Henley; Elizabeth M Ward; Susan Scott; Jiemin Ma; Robert N Anderson; Albert U Firth; Cheryll C Thomas; Farhad Islami; Hannah K Weir; Denise Riedel Lewis; Recinda L Sherman; Manxia Wu; Vicki B Benard; Lisa C Richardson; Ahmedin Jemal; Kathleen Cronin; Betsy A Kohler
Journal:  Cancer       Date:  2020-03-12       Impact factor: 6.921

Review 5.  A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States - How, what and when?

Authors:  Melinda M Davis; Michele Freeman; Jackilen Shannon; Gloria D Coronado; Kurt C Stange; Jeanne-Marie Guise; Stephanie B Wheeler; David I Buckley
Journal:  BMC Cancer       Date:  2018-01-06       Impact factor: 4.430

6.  Increasing Colorectal Cancer Screening in Health Care Systems Using Evidence-Based Interventions.

Authors:  Amy DeGroff; Krishna Sharma; Anamika Satsangi; Kristy Kenney; Djenaba Joseph; Katherine Ross; Steven Leadbetter; William Helsel; William Kammerer; Rick Firth; Tanner Rockwell; William Short; Florence Tangka; Faye Wong; Lisa Richardson
Journal:  Prev Chronic Dis       Date:  2018-08-09       Impact factor: 2.830

7.  Vital Signs: Colorectal Cancer Screening Test Use - United States, 2018.

Authors:  Djenaba A Joseph; Jessica B King; Nicole F Dowling; Cheryll C Thomas; Lisa C Richardson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-13       Impact factor: 17.586

  7 in total
  2 in total

1.  Cancer Screening Prevalence and Associated Factors Among US Adults.

Authors:  Zhen-Qiang Ma; Lisa C Richardson
Journal:  Prev Chronic Dis       Date:  2022-04-21       Impact factor: 4.354

Review 2.  Development of a Field Guide for Assessing Readiness to Implement Evidence-Based Cancer Screening Interventions in Primary Care Clinics.

Authors:  Sarah D Hohl; Stephanie Melillo; Thuy T Vu; Cam Escoffery; Amy DeGroff; Dara Schlueter; Leslie W Ross; Annette E Maxwell; Krishna P Sharma; Jennifer Boehm; Djenaba Joseph; Peggy A Hannon
Journal:  Prev Chronic Dis       Date:  2022-05-12       Impact factor: 4.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.